Drug Discovery and Therapy

The National Cancer Institute (NCI) provides preclinical cancer research, which includes the evaluation of preclinical safety and the pharmacokinetics of chemotherapeutic agents and preventive chemo. Many research laboratories also provide genetic toxicology tests for the NCI chemoprevention program, synthesize compounds for the NCI carcinogen deposit, and manufacture materials for clinical trials.

National Cancer Institute (NCI) funded by Tumor Glycome Laboratories. They are the main component of the Al-NIH trans Alliance of Glycobiologists for cancer screening and cancer risk, which is looking for glycan-based biomarkers for breast, ovarian, lung, prostate and pancreatic cancer and melanoma.

  • Hit to lead

  • Lead identification and optimization

  • Chemical biology approach to drug discovery

  • Plant-derived drugs in drug discovery

  • Computer-aided drug models in drug discovery

  • Drug transporters in drug discovery

  • A novel paradigm of drug discovery

  • Clinical Drug Development

    Related Conference of Drug Discovery and Therapy

    Drug Discovery and Therapy Conference Speakers